Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Berenike C WagnerDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0002-7691-7531
Karoline Steuer-LoddDepartment of Biochemistry, University of California, Riverside, CA 92521.
Christian GeibelCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0009-0002-2044-9422
Amelie StadelmannCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0009-0009-8729-1587
Johanna RappCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0002-4591-8312
Hannes LinkCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.
Tilman SchrammDepartment of Biochemistry, University of California, Riverside, CA 92521.
Nouneh BoodaghianDepartment of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Ansel HsiaoDepartment of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.ORCID 0000-0002-0258-6960
Eva NussbaumDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.
Heinz-Paul GrenzendorferDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.
Reinhard AlbrechtDepartment of Protein Evolution, Max Planck Institute for Developmental Biology, Tübingen 72076, Germany.
Marcus D HartmannDepartment of Protein Evolution, Max Planck Institute for Developmental Biology, Tübingen 72076, Germany.ORCID 0000-0001-6937-5677
Karl ForchhammerDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0003-3199-8101
Khaled A SelimDepartment of Organismic Interactions, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0002-2974-9483
Chambers C HughesCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0002-7000-6438
Daniel PetrasCluster of Excellence "Controlling Microbes to Fight Infections" (Excellence Cluster 2124), Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.ORCID 0000-0002-6561-3022
Funding
Defining the impact of interpersonal gut microbiota variation on oral cholera vaccine responsivenessR01AI181382 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Philip Patrick Ahern, Ansel Hsiao · 2024 to 2026
$2.3M
Small molecule signaling in regulation of gut microbiota structure and colonization resistanceR35GM158026 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI HSIAO, ANSEL · 2025 to 2025
$2.1M
Understanding the Impact of Xenobiotic Metabolism on the Gut Microbiome and Resilience against Gastrointestinal PathogensR35GM160154 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Daniel Petras · 2025 to 2026
$747k
Deutsche Forschungsgemeinschaft (DFG) EXC2124HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM158026HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM160154NIAID NIH HHS R01 AI181382NIGMS NIH HHS R35 GM158026NIGMS NIH HHS R35 GM160154Simons Foundation (SF) ID SFI-LS-ECIAMEE-00013858
6 · The paper itself
Abstract
CutA, a conserved protein across all domains of life, has been suggested to be involved in copper tolerance in bacteria, though recent studies have questioned this association, leaving its biological role unknown. To clarify its function, we studied
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Native metabolomics identifies pteridines as CutA ligands and modulators of copper binding. · full record | Socratic